Quantcast

Latest Destination Therapy Stories

2014-03-07 08:26:22

FRAMINGHAM, Mass., March 7, 2014 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the 2014 Barclays Global Healthcare Conference at 10:15 a.m. EDT on Tuesday, March 11, 2014. The conference is being held March 11-13 at Loews Miami Hotel. A live webcast of...

2014-03-04 08:33:06

AHA-Tucson Division Names SynCardia Co-Founder Copeland a Heart Hero for His Pioneering Work With Heart Transplants & the SynCardia Total Artificial Heart TUCSON, Ariz., March 4, 2014 /PRNewswire/ -- Internationally renowned heart transplant pioneer Dr. Jack G. Copeland was honored recently as a "Heart Hero" by the American Heart Association in Tucson, Arizona, for his trailblazing work saving lives with heart transplantation, the SynCardia temporary Total Artificial Heart and the use of...

2014-02-26 16:28:47

FRAMINGHAM, Mass., Feb. 26, 2014 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the Raymond James 35(th) Annual Institutional Investors Conference at 4:35 p.m. EST on Tuesday, March 4, 2014. The conference is being held March 2-5 at JW Marriott Grande...

2014-02-04 16:28:02

FRAMINGHAM, Mass., Feb. 4, 2014 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the 2014 Leerink Global Healthcare Conference at 8:55 a.m. EST on Thursday, February 13, 2014. The conference is being held February 12-13 at the Waldorf Astoria in New York...

2013-11-18 23:21:48

New Study Results Presented at AHA Scientific Sessions 2013 Show a Single Dose of Stem Cell Therapy During Surgery May Improve New LVAD Patients’ Heart Function New York, New York (PRWEB) November 18, 2013 A multicenter team of researchers within the NIH-funded Cardiothoracic Surgical Trials Network (CTSN), led by Icahn School of Medicine at Mount Sinai, have found end-stage heart failure patients who receive a surgically implanted left ventricular assist device (LVAD) heart pump may...


Word of the Day
cacodemon
  • An evil spirit; a devil.
  • A nightmare.
  • In astrology, the twelfth house of a scheme or figure of the heavens: so called from its signifying dreadful things, such as secret enemies, great losses, imprisonment, etc.
'Cacodemon' comes from a Greek term meaning 'evil genius.'
Related